Access the full text.
Sign up today, get DeepDyve free for 14 days.
T. Sørlie, C. Perou, R. Tibshirani, T. Aas, S. Geisler, H. Johnsen, T. Hastie, M. Eisen, M. Rijn, S. Jeffrey, T. Thorsen, H. Quist, J. Matese, P. Brown, D. Botstein, P. Lønning, A. Børresen-Dale (2001)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implicationsProceedings of the National Academy of Sciences of the United States of America, 98
(2002)
NHLBI morbidity and mortality chartbook
Andrew Lucas, David Greaves (2001)
Atherosclerosis: role of chemokines and macrophagesExpert Reviews in Molecular Medicine, 3
P. Ridker, C. Cannon, D. Morrow, N. Rifai, L. Rose, C. Mccabe, M. Pfeffer, E. Braunwald (2005)
C-reactive protein levels and outcomes after statin therapy.The New England journal of medicine, 352 1
E. Rhee, Won-Young Lee, Se-Yeon Kim, Byung-jin Kim, K. Sung, Bum-Su Kim, J. Kang, K. Oh, E. Oh, K. Baek, Moo-Ii Kang, H. Woo, Hyoungchun Park, Sun-Woo Kim, M. Lee, J. Park (2005)
Relationship of serum osteoprotegerin levels with coronary artery disease severity, left ventricular hypertrophy and C-reactive protein.Clinical science, 108 3
P. Libby (2002)
Inflammation in atherosclerosisNature, 420
C. Napoli, W. Palinski, G. Minno, F. D'armiento (2000)
Determination of atherogenesis in apolipoprotein E-knockout mice.Nutrition, metabolism, and cardiovascular diseases : NMCD, 10 4
M. Gunn, K. Tangemann, Carmen Tam, J. Cyster, S. Rosen, L. Williams (1998)
A chemokine expressed in lymphoid high endothelial venules promotes the adhesion and chemotaxis of naive T lymphocytes.Proceedings of the National Academy of Sciences of the United States of America, 95 1
C. Heeschen, S. Dimmeler, C. Hamm, S. Fichtlscherer, M. Simoons, A. Zeiher (2005)
Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes: comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis.Journal of the American College of Cardiology, 45 2
Yutaka Nakashima, A. Plump, E. Raines, J. Breslow, R. Ross (1994)
ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree.Arteriosclerosis and thrombosis : a journal of vascular biology, 14 1
(2001)
Expert Rev Mol Med
Chen-Hsiang Yeang, Sridhar Ramaswamy, P. Tamayo, Sayan Mukherjee, R. Rifkin, Michael Angelo, Michael Reich, E. Lander, J. Mesirov, T. Golub (2001)
Molecular classification of multiple tumor typesBioinformatics, 17 Suppl 1
S. Lee, P. Wolf, Ryan Escudero, R. Deutsch, S. Jamieson, P. Thistlethwaite (2000)
Early expression of angiogenesis factors in acute myocardial ischemia and infarction.The New England journal of medicine, 342 9
Williams Kj, I. Tabas (1999)
Atherosclerosis--an inflammatory disease.The New England journal of medicine, 340 24
R. Reddick, Sunny Zhang, N. Maeda (1994)
Atherosclerosis in mice lacking apo E. Evaluation of lesional development and progression.Arteriosclerosis and thrombosis : a journal of vascular biology, 14 1
R. Tabibiazar, R. Wagner, E. Ashley, Jennifer King, R. Ferrara, J. Spin, D. Sanan, B. Narasimhan, R. Tibshirani, P. Tsao, B. Efron, T. Quertermous (2005)
Signature patterns of gene expression in mouse atherosclerosis and their correlation to human coronary disease.Physiological genomics, 22 2
S. Paik, S. Shak, G. Tang, Chungyeul Kim, J. Baker, M. Cronin, F. Baehner, M. Walker, D. Watson, T. Park, W. Hiller, E. Fisher, D. Wickerham, J. Bryant, N. Wolmark, Genomic Health, Redwood City, S. Francisco (2004)
A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.The New England journal of medicine, 351 27
C. Glass, J. Witztum (2001)
Atherosclerosis The Road AheadCell, 104
K. Christopherson, Antoinette Hood, J. Travers, H. Ramsey, R. Hromas (2003)
Endothelial induction of the T-cell chemokine CCL21 in T-cell autoimmune diseases.Blood, 101 3
Todd Golub, Todd Golub, D. Slonim, Pablo Tamayo, Christine Huard, Michelle Gaasenbeek, J. Mesirov, Hilary Coller, M. Loh, James Downing, Michael Caligiuri, C. Bloomfield, Eric Lander (1999)
Molecular classification of cancer: class discovery and class prediction by gene expression monitoring.Science, 286 5439
S. Saadeddin, M. Habbab, G. Ferns (2002)
Markers of inflammation and coronary artery disease.Medical science monitor : international medical journal of experimental and clinical research, 8 1
M. Nagira, Toshio Imai, K. Hieshima, J. Kusuda, M. Ridanpää, S. Takagi, M. Nishimura, M. Kakizaki, H. Nomiyama, O. Yoshie (1997)
Molecular Cloning of a Novel Human CC Chemokine Secondary Lymphoid-Tissue Chemokine That Is a Potent Chemoattractant for Lymphocytes and Mapped to Chromosome 9p13*The Journal of Biological Chemistry, 272
D. Grimsditch, Suzanne Penfold, Judy Latcham, M. Vidgeon-Hart, P. Groot, G. Benson (2000)
C3H apoE(-/-) mice have less atherosclerosis than C57BL apoE(-/-) mice despite having a more atherogenic serum lipid profile.Atherosclerosis, 151 2
A. Daugherty, D. Rateri, V. King (2004)
IL-5 links adaptive and natural immunity in reducing atherosclerotic disease.The Journal of clinical investigation, 114 3
E. Economou, D. Tousoulis, Anastasia Katinioti, C. Stefanadis, A. Trikas, Christos Pitsavos, C. Tentolouris, M. Toutouza, P. Toutouzas (2001)
Chemokines in patients with ischaemic heart disease and the effect of coronary angioplasty.International journal of cardiology, 80 1
W. Kannel, D. McGee (1985)
Epidemiology of sudden death: insights from the Framingham Study.Cardiovascular clinics, 15 3
J. Lapointe, Chunde Li, J. Higgins, M. Rijn, E. Bair, K. Montgomery, M. Ferrari, L. Egevad, W. Rayford, U. Bergerheim, P. Ekman, A. DeMarzo, R. Tibshirani, D. Botstein, P. Brown, J. Brooks, J. Pollack (2004)
Gene expression profiling identifies clinically relevant subtypes of prostate cancer.Proceedings of the National Academy of Sciences of the United States of America, 101 3
C. Bursill, K. Channon, D. Greaves (2004)
The role of chemokines in atherosclerosis: recent evidence from experimental models and population geneticsCurrent Opinion in Lipidology, 15
Robert Aiello, P. Bourassa, Saralyn Lindsey, Weifan Weng, Edward Natoli, B. Rollins, Patrice Milos (1999)
Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.Arteriosclerosis, thrombosis, and vascular biology, 19 6
LESSONS FROM EPIDEMIOLOGY Sudden Death: Lessons From Subsets in Population Studies
S. Kiechl, G. Schett, G. Wenning, K. Redlich, M. Oberhollenzer, A. Mayr, P. Santer, J. Smolen, W. Poewe, J. Willeit (2004)
Osteoprotegerin Is a Risk Factor for Progressive Atherosclerosis and Cardiovascular DiseaseCirculation: Journal of the American Heart Association, 109
Nuala Murphy, K. Bruckdorfer, D. Grimsditch, P. Overend, M. Vidgeon-Hart, P. Groot, G. Benson, A. Graham (2003)
Temporal Relationships Between Circulating Levels of CC and CXC Chemokines and Developing Atherosclerosis in Apolipoprotein E*3 Leiden MiceArteriosclerosis, Thrombosis, and Vascular Biology: Journal of the American Heart Association, 23
R. Tabibiazar, R. Wagner, J. Spin, E. Ashley, B. Narasimhan, E. Rubin, B. Efron, P. Tsao, R. Tibshirani, T. Quertermous (2004)
Mouse Strain–Specific Differences in Vascular Wall Gene Expression and Their Relationship to Vascular DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 25
James Campbell, J. Hedrick, A. Zlotnik, M. Siani, D. Thompson, E. Butcher (1998)
Chemokines and the arrest of lymphocytes rolling under flow conditions.Science, 279 5349
Isabelle Guyon, J. Weston, S. Barnhill, V. Vapnik (2002)
Gene Selection for Cancer Classification using Support Vector MachinesMachine Learning, 46
K. Haley, C. Lilly, Jeong-Hee Yang, Yajun Feng, S. Kennedy, T. Turi, Johnf Thompson, G. Sukhova, P. Libby, Richard Lee (2000)
Overexpression of Eotaxin and the CCR3 Receptor in Human Atherosclerosis: Using Genomic Technology to Identify a Potential Novel Pathway of Vascular InflammationCirculation: Journal of the American Heart Association, 102
Ronald Davis, J. Seeger, Raymond Kim, L. Ruiz-Taylor, L. Moldawer, Anthony Lee, T. Huber, M. Mindrinos, R. Feezor, H. Baker, Wenzhong Xiao
Thoracoabdominal Aortic Aneurysm Repair Outcome in Patients Undergoing Genomic and Proteomic Determinants Of
P. Ridker, N. Brown, D. Vaughan, D. Harrison, J. Mehta (2004)
Established and emerging plasma biomarkers in the prediction of first atherothrombotic events.Circulation, 109 25 Suppl 1
N. Rifai, P. Ridker (2002)
Inflammatory markers and coronary heart diseaseCurrent Opinion in Lipidology, 13
Tzong-Shyuan Lee, H. Yen, Ching-Chien Pan, L. Chau (1999)
The role of interleukin 12 in the development of atherosclerosis in ApoE-deficient mice.Arteriosclerosis, thrombosis, and vascular biology, 19 3
C. Burges (1998)
A Tutorial on Support Vector Machines for Pattern RecognitionData Mining and Knowledge Discovery, 2
A. Anzuini, B. Uretsky (2004)
Covered stent septal ablation for hypertrophic obstruction cardiomyopathy.Circulation, 109 2
R. Tibshirani, T. Hastie, B. Narasimhan, Gilbert Chu (2002)
Diagnosis of multiple cancer types by shrunken centroids of gene expressionProceedings of the National Academy of Sciences of the United States of America, 99
Sridhar Ramaswamy, P. Tamayo, R. Rifkin, Sayan Mukherjee, Chen-Hsiang Yeang, Michael Angelo, C. Ladd, Michael Reich, É. Latulippe, J. Mesirov, T. Poggio, W. Gerald, M. Loda, E. Lander, T. Golub (2001)
Multiclass cancer diagnosis using tumor gene expression signaturesProceedings of the National Academy of Sciences of the United States of America, 98
Mary Chen, E. Ashley, D. Deng, A. Tsalenko, A. Deng, R. Tabibiazar, A. Ben-Dor, Brett Fenster, Eugene Yang, Jennifer King, M. Fowler, R. Robbins, F. Johnson, L. Bruhn, T. McDonagh, H. Dargie, Z. Yakhini, P. Tsao, T. Quertermous (2003)
Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac DysfunctionCirculation: Journal of the American Heart Association, 108
R. Tabibiazar, R. Wagner, A. Liao, T. Quertermous (2003)
Transcriptional Profiling of the Heart Reveals Chamber-Specific Gene Expression PatternsCirculation Research: Journal of the American Heart Association, 93
S. Parkin, J. Pritchett, D. Grimsditch, K. Bruckdorfer, P. Sahota, A. Lloyd, P. Overend, G. Benson (2004)
Circulating levels of the chemokines JE and KC in female C3H apolipoprotein-E-deficient and C57BL apolipoprotein-E-deficient mice as potential markers of atherosclerosis development.Biochemical Society transactions, 32 Pt 1
S. Stemme, Beata Faber, J. Holm, O. Wiklund, J. Witztum, G. Hansson (1995)
T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein.Proceedings of the National Academy of Sciences of the United States of America, 92
Sujong Kim, I. Sohn, Joon-Ik Ahn, Ki‐Hwan Lee, Yeon-Sook Lee, Yong Lee (2004)
Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model.Gene, 340 1
A. Luster (1998)
Chemokines--chemotactic cytokines that mediate inflammation.The New England journal of medicine, 338 7
R. Wagner, R. Tabibiazar, J. Powers, D. Bernstein, T. Quertermous (2004)
Genome-wide expression profiling of a cardiac pressure overload model identifies major metabolic and signaling pathway responses.Journal of molecular and cellular cardiology, 37 6
Tony Freemont, Christine Le-Maitre, Alex Watkins, J. Hoyland (2001)
Degeneration of intervertebral discs: current understanding of cellular and molecular events, and implications for novel therapiesExpert Reviews in Molecular Medicine, 3
At a population level, inflammatory markers have been shown to predict outcome and response to therapy in patients with atherosclerotic cardiovascular disease. However, current markers are not sufficiently sensitive or specific to provide clinical utility for managing individual patients. We hypothesize that measurement of multiple circulating disease-related inflammatory factors will be more informative, allowing the early identification of vascular wall disease activity. We have investigated whether protein microarray-based abundance measurements of circulating proteins can predict the severity of atherosclerotic disease. Using a longitudinal experimental design with apolipoprotein E-deficient mice and control C57Bl/6J and C3H/HeJ wild-type mice, we measured the time-related serum protein expression of 30 inflammatory markers using a protein microarray. We were able to identify a subset of proteins that classify and predict the severity of atherosclerotic disease with a high level of accuracy. The time-specific vascular expression of these markers was verified by showing that their gene expression in the mouse aorta correlated closely to the temporal pattern of serum protein levels. In conclusion, these data suggest that quantification of multiple disease-related inflammatory proteins can provide a more sensitive and specific methodology for assessing atherosclerotic disease activity in humans, and identify candidate biomarkers for such studies. protein microarray; biomarker; genomics; vascular
Physiological Genomics – The American Physiological Society
Published: Apr 13, 2006
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.